HRL
41
2
PX
53
-5
MMC
48
-2
FAST
40
-2
VTR
43
-3
TRV
39
-3
AIZ
66
-2
LB
37
2
INTC
39
-2
GME
68
-4
MOS
36
-3
FLS
61
-3
TMO
54
-2
EL
25
-2
FOXA
63
-3
FRT
34
-5
SYF
78
-5
WMT
67
-3
KHC
15
2
COF
49
-3
HRL
41
2
PX
53
-5
MMC
48
-2
FAST
40
-2
VTR
43
-3
TRV
39
-3
AIZ
66
-2
LB
37
2
INTC
39
-2
GME
68
-4
MOS
36
-3
FLS
61
-3
TMO
54
-2
EL
25
-2
FOXA
63
-3
FRT
34
-5
SYF
78
-5
WMT
67
-3
KHC
15
2
COF
49
-3
Financhill
Back

InflaRx NV 10K Form

Sell
49

IFRX
InflaRx NV

Last Price:
$2.62
Seasonality Move:
-6.4%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive IFRX News And Ratings

See the #1 stock for the next 7 days that we like better than IFRX

IFRX Financial Statistics

Sales & Book Value

Annual Sales: $68.3K
Cash Flow: $-11.2M
Price / Cash Flow: 0
Annual Sales: $1.24
Price / Book: 2.09

Profitability

EPS (TTM): -1.07460
Net Income (TTM): $-61.7M
Gross Margin: $-507.9K
Return on Equity: -61.55%
Return on Assets: -53.76%

InflaRx NV Earnings Forecast

Key InflaRx NV Financial Ratios

  • The Gross Profit Margin over the past 3 years for IFRX is -743.67%.
  • The Selling, General & Administrative Expenses for IFRX have been equal to 25,554.89% of Gross Profit Margin.
  • The Research & Development expenses have been 65,026.50% of Revenue.
  • The Interest Expense is -0.08% of Operating Income.
  • The Net Earning history of IFRX is -67,631.41% of Total Revenues.
  • Per Share Earnings over the last 9 years have been positive in 4 years.

InflaRx NV Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: IFRX
CUSIP: N44821
Website: inflarx.de

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 5.31
Quick Ratio: 4.34

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

IFRX Technical Analysis vs Fundamental Analysis

Sell
49
InflaRx NV (IFRX) is a Sell

Is InflaRx NV a Buy or a Sell?

  • InflaRx NV stock is rated a Sell
    The current InflaRx NV [IFRX] share price is $2.59. The Score for IFRX is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.